SENNA-S LAXATIVE WITH STOOL SOFTENER: Package Insert and Label Information

SENNA-S LAXATIVE WITH STOOL SOFTENER- docusate sodium and sennosides tablet
Basic Drugs, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Active ingredient (in each tablet)

Docusate Sodium 50mg

Sennosides from Senna Concentrate 8.6mg

Purpose

Stool softener

Laxative

Uses

  • relieves ocasional constipation (irregularity)
  • generally produces bowel movement in 6-12 hours.

Warnings

Do not use

  • if you are taking mineral oil, unless directed by a doctor.
  • laxative products for longer than 1 week, unless directed by a doctor

Ask a doctor before use if you have

  • stomach pain
  • nausea
  • vomiting
  • a sudden change in bowel movements that persists over a period of 2 weeks

Stop use and ask a doctor if

  • you have rectal bleeding
  • you fail to have a bowel movement after use of a laxative
  • These could be signs of a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of accidental overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

  • take only by mouth
  • take preferably at bedtime or as directed by a doctor
  • if you do not have a comfortable bowel movement by the second day, increase dose by one tablet (do not exceed maximum dosage) or decrease dose until you are comfortable.

age starting dosage maximum dosage
adults and children 12 years of age and over 2 tablets once a day

4 tablets twice a day

children 6 to under 12 years 1 tablet once a day 2 tablets twice a day
children 2 to under 6 years 1/2 tablet once a day 1 tablet twice a day
children under 2 years of age ask a doctor ask a doctor

Other information

  • each tablet contains: calcium 8 mg, sodium 3 mg
  • store between 15° — 30°C (59° — 86°F)

Inactive ingredients

Croscarmellose sodium, D&C Yellow #10, dicalcium phosphate, FD&C Yellow # 6, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, talc, titanium dioxide

Questions?

937-898-4010

http://druginserts.com/lib/images-otc/senna-s-laxative-with-stool-softener/01b_pdp_senna-s-laxative-w-stool-softner.jpg

//druginserts.com/lib/images-otc/senna-s-laxative-with-stool-softener/01b_df1_senna-s-300x183.jpg
(click image for full-size original)
//druginserts.com/lib/images-otc/senna-s-laxative-with-stool-softener/01b_df2_senna-s-300x110.jpg
(click image for full-size original)
SENNA-S LAXATIVE WITH STOOL SOFTENER
sennosides tablet
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:0761-0910
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DOCUSATE SODIUM (DOCUSATE) DOCUSATE SODIUM 50 mg
SENNOSIDES (SENNOSIDES) SENNOSIDES 8.6 mg
Inactive Ingredients
Ingredient Name Strength
CROSCARMELLOSE SODIUM
D&C YELLOW NO. 10
ANHYDROUS DIBASIC CALCIUM PHOSPHATE
FD&C YELLOW NO. 6
MAGNESIUM STEARATE
CELLULOSE, MICROCRYSTALLINE
POLYETHYLENE GLYCOL, UNSPECIFIED
POLYVINYL ALCOHOL, UNSPECIFIED
TALC
TITANIUM DIOXIDE
Product Characteristics
Color orange Score no score
Shape ROUND Size 9mm
Flavor Imprint Code PH32
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0761-0910-02 100 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph not final part334 12/15/2021
Labeler — Basic Drugs, Inc. (052155082)

Revised: 01/2022 Basic Drugs, Inc.

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2022. All Rights Reserved.